PIECZENIK v. BAYER CORPORATION
3:10-cv-02230
Overview
Case Number
3:10-cv-02230
Filing Date
2010-05-04
Status
Litigation filed
Court
District Court, D. New Jersey
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. New Jersey
Presiding Judge
Joel A. Pisano
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
COMPLAINT against BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., HOFFMAN-LA ROCHE INC., JOHN DOES 1 THROUGH 61, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., QIAGEN INCORPORATED, ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC. ( Filing fee $ 350 receipt number TRE001620.) JURY DEMANDED., filed by GEORGE PIECZENIK. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(eaj) (Main Document 1 replaced on 5/5/2010) (eaj). (Entered: 05/04/2010)
2010-05-04
1
COMPLAINT against BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., HOFFMAN-LA ROCHE INC., JOHN DOES 1 THROUGH 61, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., QIAGEN INCORPORATED, ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC. ( Filing fee $ 350 receipt number TRE001620.) JURY DEMANDED., filed by GEORGE PIECZENIK. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(eaj) (Main Document 1 replaced on 5/5/2010) (eaj). (Entered: 05/04/2010)
2010-05-04
2
COMPLAINT against BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., HOFFMAN-LA ROCHE INC., JOHN DOES 1 THROUGH 61, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., QIAGEN INCORPORATED, ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC. ( Filing fee $ 350 receipt number TRE001620.) JURY DEMANDED., filed by GEORGE PIECZENIK. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A)(eaj) (Main Document 1 replaced on 5/5/2010) (eaj). (Entered: 05/04/2010)
2010-05-04
2
AO120 Patent/Trademark Form filed. (eaj) (Entered: 05/04/2010)
2010-05-04
1
SUMMONS ISSUED as to BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., HOFFMAN-LA ROCHE INC., NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., QIAGEN INCORPORATED, ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC. with answer to complaint due within 21 days. (eaj) (Entered: 05/04/2010)
2010-05-04
1
CONSENT & REGISTRATION FORM TO RECEIVE DOCUMENTS ELECTRONICALLY by GEORGE PIECZENIK (eaj) (Entered: 05/06/2010)
2010-05-06
1
SUMMONS Returned Executed by GEORGE PIECZENIK. BAYER CORPORATION served on 5/12/2010, answer due 6/2/2010; BAYER CROPSCIENCE (New Jersey) INC. served on 5/12/2010, answer due 6/2/2010; BAYER HEALTHCARE LLC served on 5/12/2010, answer due 6/2/2010; BAYER HEALTHCARE PHARMACEUTICALS, INC. served on 5/12/2010, answer due 6/2/2010; BAYER MATERIALSCIENCE LLC served on 5/12/2010, answer due 6/2/2010; BAYER PHARMA CHEMICALS INC. served on 5/12/2010, answer due 6/2/2010; BAYER PHARMACEUTICALS CORPORATION served on 5/12/2010, answer due 6/2/2010; BOEHRINGER INGELHEIM VETMEDICA, INC. served on 5/12/2010, answer due 6/2/2010; BOEHRINGER INGELHEIMROXANE, INC. served on 5/12/2010, answer due 6/2/2010; BRACCO DIAGNOSTICS INC. served on 5/12/2010, answer due 6/2/2010; HOFFMAN-LA ROCHE INC. served on 5/11/2010, answer due 6/1/2010; NOVARTIS CORPORATION served on 5/12/2010, answer due 6/2/2010; NOVARTIS PHARMACEUTICAL CORPORATION served on 5/12/2010, answer due 6/2/2010; NOVARTIS VACCINES AND DIAGNOSTICS, INC. served on 5/12/2010, answer due 6/2/2010; QIAGEN INCORPORATED served on 5/12/2010, answer due 6/2/2010; ROCHE DIAGNOSTICS CORPORATION served on 5/12/2010, answer due 6/2/2010; ROCHE LABORATORIES INC. served on 5/12/2010, answer due 6/2/2010; ROCHE MOLECULAR SYSTEMS, INC. served on 5/12/2010, answer due 6/2/2010; SIEMENS CORPORATION served on 5/12/2010, answer due 6/2/2010; SIEMENS DIAGNOSTICS FINANCE CO. LLC served on 5/12/2010, answer due 6/2/2010; SIEMENS HEALTHCARE DIAGNOSTICS INC. served on 5/12/2010, answer due 6/2/2010; SIEMENS MEDICAL SOLUTIONS USA, INC. served on 5/12/2010, answer due 6/2/2010; SYNGENTA CROP PROTECTION, INC. served on 5/12/2010, answer due 6/2/2010; SYNGENTA SEEDS, INC. served on 5/12/2010, answer due 6/2/2010. (gxh) (Entered: 05/14/2010)
2010-05-14
1
NOTICE pro se (Non-Prisoner) to receive documents electronically by GEORGE PIECZENIK (lk) (Entered: 05/14/2010)
2010-05-14
1
Application and Proposed Order for Clerk's Order to extend time to answer as to Novartis Corporation, Novartis Pharmaceuticals Corporation, and Novartis Vaccines and Diagnostics, Inc... (HELLER, WILLIAM) (Entered: 05/25/2010)
2010-05-25
1
CLERKS TEXT ORDER - The Application for a Clerks Order Extending Time to Answer - Document #7 submitted by W. Heller on 5/25/2010 has been GRANTED. The answer due date has been set for 6/17/2010 for Novartis dfts. (ss, )
2010-05-26
1
No Actions
NOTICE of Appearance by LIZA M. WALSH on behalf of QIAGEN INCORPORATED (WALSH, LIZA) (Entered: 05/28/2010)
2010-05-28
1
NOTICE of Appearance by RUKHSANAH L. LIGHARI on behalf of QIAGEN INCORPORATED (LIGHARI, RUKHSANAH) (Entered: 05/28/2010)
2010-05-28
1
Application and Proposed Order for Clerk's Order to extend time to answer as to Qiagen Incorporated.. (WALSH, LIZA) (Entered: 05/28/2010)
2010-05-28
1
Application and Proposed Order for Clerk's Order to extend time to answer as to Boehringer Ingelheim Roxane, Inc. and Boehringer Ingelheim Vetmedica, Inc... (HELLER, WILLIAM) (Entered: 05/28/2010)
2010-05-28
1
Application and Proposed Order for Clerk's Order to extend time to answer as to Siemens Corporation, Siemens Diagnostics Finance Co. LLC, Siemens Healthcare Diagnostics Inc., and Siemens Medical Solutions USA, Inc... (HELLER, WILLIAM) (Entered: 05/28/2010)
2010-05-28
1
Application and Proposed Order for Clerk's Order to extend time to answer as to defendants Roche Laboratories Inc., Roche Molecular Systems, Inc., Roche Diagnostics Corporation, and Hoffman-La Roche Inc... (Attachments: # 1 Certificate of Service)(DELORENZI, DAVID) (Entered: 06/01/2010)
2010-06-01
1
Application and Proposed Order for Clerk's Order to extend time to answer as to defendants Roche Laboratories Inc., Roche Molecular Systems, Inc., Roche Diagnostics Corporation, and Hoffman-La Roche Inc... (Attachments: # 1 Certificate of Service)(DELORENZI, DAVID) (Entered: 06/01/2010)
2010-06-01
2
Application and Proposed Order for Clerk's Order to extend time to answer as to Syngenta Crop Protection, Inc. and Syngenta Seeds, Inc... (Attachments: # 1 Certificate of Service)(MCKENNA, KEVIN) (Entered: 06/01/2010)
2010-06-01
1
Application and Proposed Order for Clerk's Order to extend time to answer as to Syngenta Crop Protection, Inc. and Syngenta Seeds, Inc... (Attachments: # 1 Certificate of Service)(MCKENNA, KEVIN) (Entered: 06/01/2010)
2010-06-01
2
CLERKS TEXT ORDER - The Application for a Clerks Order Extending Time to Answer - Document # 11 submitted by W. Heller, Esq. on 5/28/2010 has been GRANTED. The answer due date has been set for 6/16/2010. (gxh)
2010-06-01
1
No Actions
CLERKS TEXT ORDER - The Application for a Clerks Order Extending Time to Answer - Document # 12 submitted by W. Heller, Esq. on 5/28/2010 has been GRANTED. The answer due date has been set for 6/16/2010. (gxh)
2010-06-01
1
No Actions
CLERKS TEXT ORDER - The Application for a Clerks Order Extending Time to Answer - Document # 10 submitted by Liza Walsh, Esq. on 5/28/2010 has been GRANTED. The answer due date has been set for 6/16/2010. (gxh)
2010-06-01
1
No Actions
NOTICE of Appearance by CARRIE ANN LONGSTAFF on behalf of HOFFMAN-LA ROCHE INC., ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC. (LONGSTAFF, CARRIE) (Entered: 06/02/2010)
2010-06-02
1
APPLICATION/PETITION for Stephen S. Rabinowitz Admission Pro Hac Vice for by HOFFMAN-LA ROCHE INC., ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC.. (Attachments: # 1 Declaration of Stephen S. Rabinowitz, # 2 Text of Proposed Order, # 3 Certificate of Service)(DELORENZI, DAVID) (Entered: 06/02/2010)
2010-06-02
1
APPLICATION/PETITION for Stephen S. Rabinowitz Admission Pro Hac Vice for by HOFFMAN-LA ROCHE INC., ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC.. (Attachments: # 1 Declaration of Stephen S. Rabinowitz, # 2 Text of Proposed Order, # 3 Certificate of Service)(DELORENZI, DAVID) (Entered: 06/02/2010)
2010-06-02
2
APPLICATION/PETITION for Stephen S. Rabinowitz Admission Pro Hac Vice for by HOFFMAN-LA ROCHE INC., ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC.. (Attachments: # 1 Declaration of Stephen S. Rabinowitz, # 2 Text of Proposed Order, # 3 Certificate of Service)(DELORENZI, DAVID) (Entered: 06/02/2010)
2010-06-02
2
APPLICATION/PETITION for Stephen S. Rabinowitz Admission Pro Hac Vice for by HOFFMAN-LA ROCHE INC., ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC.. (Attachments: # 1 Declaration of Stephen S. Rabinowitz, # 2 Text of Proposed Order, # 3 Certificate of Service)(DELORENZI, DAVID) (Entered: 06/02/2010)
2010-06-02
2
Application and Proposed Order for Clerk's Order to extend time to answer as to Bayer Corporation, Bayer Healthcare, LLC, Bayer Healthcare Pharmaceuticals, Inc., Bayer Pharma Chemicals, Inc., and Bayer Materialscience, LLC. Attorney ROBERT M. GOODMAN for BAYER CORPORATION,ROBERT M. GOODMAN for BAYER HEALTHCARE LLC,ROBERT M. GOODMAN for BAYER HEALTHCARE PHARMACEUTICALS, INC.,ROBERT M. GOODMAN for BAYER MATERIALSCIENCE LLC,ROBERT M. GOODMAN for BAYER PHARMA CHEMICALS INC. added. (Attachments: # 1 Text of Proposed Order)(GOODMAN, ROBERT) (Entered: 06/02/2010)
2010-06-02
1
Application and Proposed Order for Clerk's Order to extend time to answer as to Bayer Corporation, Bayer Healthcare, LLC, Bayer Healthcare Pharmaceuticals, Inc., Bayer Pharma Chemicals, Inc., and Bayer Materialscience, LLC. Attorney ROBERT M. GOODMAN for BAYER CORPORATION,ROBERT M. GOODMAN for BAYER HEALTHCARE LLC,ROBERT M. GOODMAN for BAYER HEALTHCARE PHARMACEUTICALS, INC.,ROBERT M. GOODMAN for BAYER MATERIALSCIENCE LLC,ROBERT M. GOODMAN for BAYER PHARMA CHEMICALS INC. added. (Attachments: # 1 Text of Proposed Order)(GOODMAN, ROBERT) (Entered: 06/02/2010)
2010-06-02
2
Granting 13 Application and Clerk's text only Order to extend time to answer as to ROCHE LABORATORIES INC. answer due 6/16/2010; ROCHE MOLECULAR SYSTEMS, INC. answer due 6/16/2010; HOFFMAN-LA ROCHE INC. answer due 6/16/2010; ROCHE DIAGNOSTICS CORPORATION answer due 6/16/2010 Attorney DAVID E. DELORENZI for ROCHE LABORATORIES INC.,DAVID E. DELORENZI for ROCHE MOLECULAR SYSTEMS, INC.,DAVID E. DELORENZI for HOFFMAN-LA ROCHE INC.,DAVID E. DELORENZI for ROCHE DIAGNOSTICS CORPORATION added.. (lk, )
2010-06-02
1
No Actions
Granting 14 Application and Clerk's text only Order to extend time to answer as to SYNGENTA CROP PROTECTION, INC. answer due 6/16/2010; SYNGENTA SEEDS, INC. answer due 6/16/2010 Attorney KEVIN J. MCKENNA for SYNGENTA CROP PROTECTION, INC.,KEVIN J. MCKENNA for SYNGENTA SEEDS, INC. added.. (lk)
2010-06-02
1
No Actions
Granting 17 Application and Clerk's text only Order to extend time to answer as to BAYER MATERIALSCIENCE LLC answer due 6/16/2010; BAYER CORPORATION answer due 6/16/2010; BAYER PHARMA CHEMICALS INC. answer due 6/16/2010; BAYER HEALTHCARE LLC answer due 6/16/2010; BAYER HEALTHCARE PHARMACEUTICALS, INC. answer due 6/16/2010. (lk)
2010-06-03
1
No Actions
NOTICE of Appearance by WILLIAM J. HELLER on behalf of BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC. (HELLER, WILLIAM) (Entered: 06/04/2010)
2010-06-04
1
NOTICE of Appearance by SYMONE J. REDWINE on behalf of BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC. (REDWINE, SYMONE) (Entered: 06/04/2010)
2010-06-04
1
NOTICE of Appearance by JONATHAN M.H. SHORT on behalf of BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC. (SHORT, JONATHAN) (Entered: 06/04/2010)
2010-06-04
1
NOTICE of Appearance by CYNTHIA STENCEL BETZ on behalf of BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC. (BETZ, CYNTHIA) (Entered: 06/04/2010)
2010-06-04
1
NOTICE of Appearance by KEVIN J. MCKENNA on behalf of SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC. (MCKENNA, KEVIN) (Entered: 06/10/2010)
2010-06-10
1
NOTICE of Appearance by ALICE HAO I LEE on behalf of SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC. (LEE, ALICE) (Entered: 06/10/2010)
2010-06-10
1
MOTION for Leave to Appear Pro Hac Vice by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. (Attachments: # 1 Certification of W Heller with Exhibits, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
1
MOTION for Leave to Appear Pro Hac Vice by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. (Attachments: # 1 Certification of W Heller with Exhibits, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
2
MOTION for Leave to Appear Pro Hac Vice by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. (Attachments: # 1 Certification of W Heller with Exhibits, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
2
MOTION for Leave to Appear Pro Hac Vice by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. (Attachments: # 1 Certification of W Heller with Exhibits, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
2
Corporate Disclosure Statement by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. (HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
1
MOTION for Leave to Appear Pro Hac Vice by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. (Attachments: # 1 Certification of William J Heller with exhibits, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
1
MOTION for Leave to Appear Pro Hac Vice by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. (Attachments: # 1 Certification of William J Heller with exhibits, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
2
MOTION for Leave to Appear Pro Hac Vice by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. (Attachments: # 1 Certification of William J Heller with exhibits, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
2
MOTION for Leave to Appear Pro Hac Vice by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. (Attachments: # 1 Certification of William J Heller with exhibits, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/11/2010)
2010-06-11
2
Corporate Disclosure Statement by QIAGEN INCORPORATED identifying Qiagen N.V. as Corporate Parent.. (WALSH, LIZA) (Entered: 06/14/2010)
2010-06-14
1
MOTION to Dismiss by QIAGEN INCORPORATED. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(WALSH, LIZA) (Entered: 06/14/2010)
2010-06-14
1
MOTION to Dismiss by QIAGEN INCORPORATED. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(WALSH, LIZA) (Entered: 06/14/2010)
2010-06-14
2
MOTION to Dismiss by QIAGEN INCORPORATED. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(WALSH, LIZA) (Entered: 06/14/2010)
2010-06-14
2
MOTION to Dismiss by QIAGEN INCORPORATED. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(WALSH, LIZA) (Entered: 06/14/2010)
2010-06-14
2
Corporate Disclosure Statement by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. (HELLER, WILLIAM) (Entered: 06/14/2010)
2010-06-14
1
MOTION to Dismiss by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service, # 4 Certification)(HELLER, WILLIAM) (Entered: 06/14/2010)
2010-06-14
1
MOTION to Dismiss by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service, # 4 Certification)(HELLER, WILLIAM) (Entered: 06/14/2010)
2010-06-14
2
MOTION to Dismiss by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service, # 4 Certification)(HELLER, WILLIAM) (Entered: 06/14/2010)
2010-06-14
2
MOTION to Dismiss by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service, # 4 Certification)(HELLER, WILLIAM) (Entered: 06/14/2010)
2010-06-14
2
MOTION to Dismiss by NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service, # 4 Certification)(HELLER, WILLIAM) (Entered: 06/14/2010)
2010-06-14
2
NOTICE of Appearance by ROBERT M. GOODMAN on behalf of BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC. (GOODMAN, ROBERT) (Entered: 06/14/2010)
2010-06-14
1
Letter from Thomas K. Murphy III. (Attachments: # 1 Stipulation)(GOODMAN, ROBERT) (Entered: 06/14/2010)
2010-06-14
1
Letter from Thomas K. Murphy III. (Attachments: # 1 Stipulation)(GOODMAN, ROBERT) (Entered: 06/14/2010)
2010-06-14
2
Set Deadlines as to 24 MOTION for Leave to Appear Pro Hac Vice, 26 MOTION for Leave to Appear Pro Hac Vice. Motion set for 7/6/2010 before Magistrate Judge Tonianne J. Bongiovanni. The motion will be decided on the papers. No appearances required unless notified by the court. (lk)
2010-06-14
1
No Actions
STIPULATION of Dismissal with Prejudice (Proposed Order) by HOFFMAN-LA ROCHE INC., ROCHE DIAGNOSTICS CORPORATION, ROCHE LABORATORIES INC., ROCHE MOLECULAR SYSTEMS, INC.. (DELORENZI, DAVID) (Entered: 06/15/2010)
2010-06-15
1
MOTION to Dismiss by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/15/2010)
2010-06-15
1
MOTION to Dismiss by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/15/2010)
2010-06-15
2
MOTION to Dismiss by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/15/2010)
2010-06-15
2
MOTION to Dismiss by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/15/2010)
2010-06-15
2
Corporate Disclosure Statement by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (HELLER, WILLIAM) (Entered: 06/15/2010)
2010-06-15
1
ORDER granting leave to appear pro hace vice as to Stephen S. Rabinowitz, Esq. on behalf of certain Defts. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/15/2010. (gxh) (Entered: 06/16/2010)
2010-06-15
1
Set Deadlines as to 28 MOTION to Dismiss. Motion set for 7/19/2010 before Judge Freda L. Wolfson. The motion will be decided on the papers. No appearances required unless notified by the court. (lk)
2010-06-15
1
No Actions
STIPULATION AND ORDER that Bayer Corporation, Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc., Bayer Cropscience (New Jersey) Inc., Bayer Pharma Chemicals Inc., and Bayer Materialscience LLC acknowledge that they have each received a copy of the complaint; that the aforementioned Defts' time to answer or otherwise respond to the Complaint is extended to 7/12/2010. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/16/2010. (gxh) (Entered: 06/16/2010)
2010-06-16
1
MOTION to Dismiss by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certification per Rule 11.2, # 4 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/16/2010)
2010-06-16
1
MOTION to Dismiss by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certification per Rule 11.2, # 4 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/16/2010)
2010-06-16
2
MOTION to Dismiss by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certification per Rule 11.2, # 4 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/16/2010)
2010-06-16
2
MOTION to Dismiss by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certification per Rule 11.2, # 4 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/16/2010)
2010-06-16
2
MOTION to Dismiss by BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC.. Responses due by 7/6/2010 (Attachments: # 1 Brief, # 2 Text of Proposed Order, # 3 Certification per Rule 11.2, # 4 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/16/2010)
2010-06-16
2
Corporate Disclosure Statement by SYNGENTA CROP PROTECTION, INC. identifying Syngenta AG as Corporate Parent.. (MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
1
Corporate Disclosure Statement by SYNGENTA SEEDS, INC. identifying Syngenta AG as Corporate Parent.. (MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
1
APPLICATION/PETITION for Pro Hac Vice Admission of Daniel J. Brown and Heather D. Redmond for by SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC.. (Attachments: # 1 Certification of Daniel J. Brown, # 2 Certification of Heather D. Redmond, # 3 Text of Proposed Order)(MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
1
APPLICATION/PETITION for Pro Hac Vice Admission of Daniel J. Brown and Heather D. Redmond for by SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC.. (Attachments: # 1 Certification of Daniel J. Brown, # 2 Certification of Heather D. Redmond, # 3 Text of Proposed Order)(MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
2
APPLICATION/PETITION for Pro Hac Vice Admission of Daniel J. Brown and Heather D. Redmond for by SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC.. (Attachments: # 1 Certification of Daniel J. Brown, # 2 Certification of Heather D. Redmond, # 3 Text of Proposed Order)(MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
2
APPLICATION/PETITION for Pro Hac Vice Admission of Daniel J. Brown and Heather D. Redmond for by SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC.. (Attachments: # 1 Certification of Daniel J. Brown, # 2 Certification of Heather D. Redmond, # 3 Text of Proposed Order)(MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
2
MOTION to Dismiss the Complaint Pursuant to Federal Rule of Civil Procedure 12(b)(6) by SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC.. (Attachments: # 1 Brief, # 2 Text of Proposed Order)(MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
1
MOTION to Dismiss the Complaint Pursuant to Federal Rule of Civil Procedure 12(b)(6) by SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC.. (Attachments: # 1 Brief, # 2 Text of Proposed Order)(MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
2
MOTION to Dismiss the Complaint Pursuant to Federal Rule of Civil Procedure 12(b)(6) by SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC.. (Attachments: # 1 Brief, # 2 Text of Proposed Order)(MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
2
CERTIFICATE OF SERVICE by SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC. re 39 Corporate Disclosure Statement, 42 MOTION to Dismiss the Complaint Pursuant to Federal Rule of Civil Procedure 12(b)(6), 40 Corporate Disclosure Statement, 41 Application/Petition, (MCKENNA, KEVIN) (Entered: 06/16/2010)
2010-06-16
1
Set Deadlines as to 34 MOTION to Dismiss. Motion set for 7/19/2010 before Judge Freda L. Wolfson. The motion will be decided on the papers. No appearances required unless notified by the court. (lk)
2010-06-16
1
No Actions
Set Deadlines as to 38 MOTION to Dismiss, 42 MOTION to Dismiss the Complaint Pursuant to Federal Rule of Civil Procedure 12(b)(6). Motion set for 7/19/2010 before Judge Freda L. Wolfson. The motion will be decided on the papers. No appearances required unless notified by the court. (lk)
2010-06-17
1
No Actions
ORDER REASSIGNING CASE frin JUDGE FREDA L. WOLFSON to JUDGE JOEL A. PISANO. Signed by Chief Judge Garrett E. Brown, Jr. on 6/22/2010. (eaj) (Entered: 06/22/2010)
2010-06-22
1
MOTION for Leave to Appear Pro Hac Vice by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Certification William Heller, # 2 Certification Charles Lipsey, # 3 Certification Susan Griffin, # 4 Certification Courtney Casp, # 5 Certification Victoria Lee, # 6 Text of Proposed Order, # 7 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/22/2010)
2010-06-22
1
MOTION for Leave to Appear Pro Hac Vice by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Certification William Heller, # 2 Certification Charles Lipsey, # 3 Certification Susan Griffin, # 4 Certification Courtney Casp, # 5 Certification Victoria Lee, # 6 Text of Proposed Order, # 7 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/22/2010)
2010-06-22
2
MOTION for Leave to Appear Pro Hac Vice by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Certification William Heller, # 2 Certification Charles Lipsey, # 3 Certification Susan Griffin, # 4 Certification Courtney Casp, # 5 Certification Victoria Lee, # 6 Text of Proposed Order, # 7 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/22/2010)
2010-06-22
2
MOTION for Leave to Appear Pro Hac Vice by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Certification William Heller, # 2 Certification Charles Lipsey, # 3 Certification Susan Griffin, # 4 Certification Courtney Casp, # 5 Certification Victoria Lee, # 6 Text of Proposed Order, # 7 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/22/2010)
2010-06-22
2
MOTION for Leave to Appear Pro Hac Vice by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Certification William Heller, # 2 Certification Charles Lipsey, # 3 Certification Susan Griffin, # 4 Certification Courtney Casp, # 5 Certification Victoria Lee, # 6 Text of Proposed Order, # 7 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/22/2010)
2010-06-22
2
MOTION for Leave to Appear Pro Hac Vice by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Certification William Heller, # 2 Certification Charles Lipsey, # 3 Certification Susan Griffin, # 4 Certification Courtney Casp, # 5 Certification Victoria Lee, # 6 Text of Proposed Order, # 7 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/22/2010)
2010-06-22
2
MOTION for Leave to Appear Pro Hac Vice by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Certification William Heller, # 2 Certification Charles Lipsey, # 3 Certification Susan Griffin, # 4 Certification Courtney Casp, # 5 Certification Victoria Lee, # 6 Text of Proposed Order, # 7 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/22/2010)
2010-06-22
2
MOTION for Leave to Appear Pro Hac Vice by SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC.. (Attachments: # 1 Certification William Heller, # 2 Certification Charles Lipsey, # 3 Certification Susan Griffin, # 4 Certification Courtney Casp, # 5 Certification Victoria Lee, # 6 Text of Proposed Order, # 7 Certificate of Service)(HELLER, WILLIAM) (Entered: 06/22/2010)
2010-06-22
2
Set Deadlines as to 45 MOTION for Leave to Appear Pro Hac Vice. Motion set for 7/19/2010 before Magistrate Judge Tonianne J. Bongiovanni. The motion will be decided on the papers. No appearances required unless notified by the court. (ss, )
2010-06-23
1
No Actions
STIPULATION AND ORDER of dismissal with prejudice as to Defts Hoffmann-La Roche Inc., Roche Laboratories Inc., Roche Diagnostics Corporation and Roche Molecular Systems, Inc.. Signed by Judge Joel A. Pisano on 6/25/2010. (gxh) (Entered: 06/25/2010)
2010-06-25
1
ORDER that Pltf's complaints are hereby DISMISSED WITHOUT PREJUDICE to the filing of an amended complaint; that Civil Action Nos. 10-2230, 10-2253, 10-2296 and 10-2327 are consolidated for all purposes under Civil Action No. 10-2230; that Pltf may file a single consolidated amended complaint in Civil Action No. 10-2230 conforming to all requirements of Rule 8 within 30 days from the date of entry of this Order; that all pending motions to dismiss the complaint are hereby DISMISSED WITHOUT PREJUDICE as moot; that upon the filing of an amended complaint, the Court shall appoint from among defense counsel a liaison counsel. Signed by Judge Joel A. Pisano on 6/25/2010. (gxh) (Entered: 06/28/2010)
2010-06-25
1
LETTER ORDER withdrawing the pro hac vice application of Stephen S. Rabinowitz, Esq. which was granted on 6/15/2010; waiving the requirement for payment of the pro hac vice admission fees for this attorney. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/28/2010. (gxh) (Entered: 06/28/2010)
2010-06-28
1
Notice of Request by Pro Hac Vice Amy K. Wigmore and Tracey C. Allen to receive Notices of Electronic Filings. (BUCKINGHAM, STEPHEN) (Entered: 06/28/2010)
2010-06-28
1
LETTER ORDER that all of the pending pro hac vice motions and applications in these four cases are dismissed without prejudice as moot; that in the event that a Deft who has filed a pro hac vice motion or application is named as a Deft in the consolidated amended complaint in Civil Action No. 10-2230, the Court will deem their motion or application to be re-filed in the consolidated case after receiving an informal request for the Court to do so; terminating 24, 26 and 45 MOTION for Leave to Appear Pro Hac Vice. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/29/2010. (gxh) (Entered: 06/29/2010)
2010-06-29
1
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
1
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
AMENDED COMPLAINT against ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DIVERSA CHEMICAL TECHNOLOGIES(NJ), INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHN DOES 1 THROUGH 61, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC, filed by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H (Part 1 of 2), # 9 Exhibit H (Part 2 of 2), # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L)(gxh) (Entered: 07/27/2010)
2010-07-27
2
ORDER that the Court hereby appoints Liza M. Walsh, Esq. as liaison counsel for Defts; that liaison counsel shall advise the Court whether service of the amended complaint has been completed as to all Defts and if not completed, then when such service is complete; that liaison counsel shall coordinate a consolidated response to the amended complaint; that Defts shall have 45 days from the date of this Order or the date the last Deft is served with the amended complaint to file their response to the amended complaint. Signed by Judge Joel A. Pisano on 8/3/2010. (gxh) (Entered: 08/03/2010)
2010-08-03
1
NOTICE by OSI PHARMACEUTICALS, INC. Notice of Withdrawal (PATUNAS, MICHAEL) (Entered: 08/03/2010)
2010-08-03
1
MOTION for Leave to Appear Pro Hac Vice by BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., SCHERING BERLIN INC.. (Attachments: # 1 Certification of Robert M. Goodman, # 2 Certification of Robert J. Koch, # 3 Text of Proposed Order)(GOODMAN, ROBERT) (Entered: 08/10/2010)
2010-08-10
1
MOTION for Leave to Appear Pro Hac Vice by BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., SCHERING BERLIN INC.. (Attachments: # 1 Certification of Robert M. Goodman, # 2 Certification of Robert J. Koch, # 3 Text of Proposed Order)(GOODMAN, ROBERT) (Entered: 08/10/2010)
2010-08-10
2
MOTION for Leave to Appear Pro Hac Vice by BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., SCHERING BERLIN INC.. (Attachments: # 1 Certification of Robert M. Goodman, # 2 Certification of Robert J. Koch, # 3 Text of Proposed Order)(GOODMAN, ROBERT) (Entered: 08/10/2010)
2010-08-10
2
MOTION for Leave to Appear Pro Hac Vice by BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., SCHERING BERLIN INC.. (Attachments: # 1 Certification of Robert M. Goodman, # 2 Certification of Robert J. Koch, # 3 Text of Proposed Order)(GOODMAN, ROBERT) (Entered: 08/10/2010)
2010-08-10
2
Set Deadlines as to 54 MOTION for Leave to Appear Pro Hac Vice. Motion set for 9/7/2010 before Magistrate Judge Tonianne J. Bongiovanni. The motion will be decided on the papers. No appearances required unless notified by the court. (lk)
2010-08-11
1
No Actions
Letter from Liza M. Walsh. (WALSH, LIZA) (Entered: 08/18/2010)
2010-08-18
1
Letter from Liza M. Walsh re 50 Order, Terminate Motions,,,,. (WALSH, LIZA) (Entered: 08/18/2010)
2010-08-18
1
ORDER granting 54 Motion for Leave to Appear Pro Hac Vice as to Robert J. Koch, Esq. on behalf of Bayer Defts. Signed by Magistrate Judge Tonianne J. Bongiovanni on 8/19/2010. (gxh) (Entered: 08/19/2010)
2010-08-19
1
Letter from Pltf Dr. George Pieczenik to Judge Pisano requesting that the Judge order the Court Clerk to issue two new summonses so he may re-serve Dfts with Amended Complaint. (Attachments: # 1 Exhibit A)(eaj) (Entered: 08/20/2010)
2010-08-20
1
Letter from Pltf Dr. George Pieczenik to Judge Pisano requesting that the Judge order the Court Clerk to issue two new summonses so he may re-serve Dfts with Amended Complaint. (Attachments: # 1 Exhibit A)(eaj) (Entered: 08/20/2010)
2010-08-20
2
LETTER ORDER granting the pro hac vice motions/applications listed herein so long as Counsel files the applicant's certification and payment of the requisite fees in accordance with Local Civil Rule 101.1(c). Signed by Magistrate Judge Tonianne J. Bongiovanni on 8/19/2010. (mmh) (Entered: 08/20/2010)
2010-08-20
1
Certification of Donald A. Robinson (refiled under Consolidated Action pursuant to August 19, 2010 Order) on behalf of CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., JOHNSON & JOHNSON, ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC.. (Attachments: # 1 Declaration of David Pritikin, Esq., # 2 Declaration of Lisa Schneider, Esq., # 3 Declaration 0f Constantine Koutsoubas)(ROBINSON, DONALD) (Entered: 08/26/2010)
2010-08-26
1
Certification of Donald A. Robinson (refiled under Consolidated Action pursuant to August 19, 2010 Order) on behalf of CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., JOHNSON & JOHNSON, ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC.. (Attachments: # 1 Declaration of David Pritikin, Esq., # 2 Declaration of Lisa Schneider, Esq., # 3 Declaration 0f Constantine Koutsoubas)(ROBINSON, DONALD) (Entered: 08/26/2010)
2010-08-26
2
Certification of Donald A. Robinson (refiled under Consolidated Action pursuant to August 19, 2010 Order) on behalf of CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., JOHNSON & JOHNSON, ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC.. (Attachments: # 1 Declaration of David Pritikin, Esq., # 2 Declaration of Lisa Schneider, Esq., # 3 Declaration 0f Constantine Koutsoubas)(ROBINSON, DONALD) (Entered: 08/26/2010)
2010-08-26
2
Certification of Donald A. Robinson (refiled under Consolidated Action pursuant to August 19, 2010 Order) on behalf of CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., JOHNSON & JOHNSON, ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC.. (Attachments: # 1 Declaration of David Pritikin, Esq., # 2 Declaration of Lisa Schneider, Esq., # 3 Declaration 0f Constantine Koutsoubas)(ROBINSON, DONALD) (Entered: 08/26/2010)
2010-08-26
2
Notice of Request by Pro Hac Vice David T. Pritikin, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3290393.) (ROBINSON, DONALD) (Entered: 08/26/2010)
2010-08-26
1
Notice of Request by Pro Hac Vice Lisa Schneider, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3290405.) (ROBINSON, DONALD) (Entered: 08/26/2010)
2010-08-26
1
Notice of Request by Pro Hac Vice Constantine Koutsoubas, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3290412.) (ROBINSON, DONALD) (Entered: 08/26/2010)
2010-08-26
1
Notice of Request by Pro Hac Vice Robert J. Koch, Esq. to receive Notices of Electronic Filings. (GOODMAN, ROBERT) (Entered: 08/30/2010)
2010-08-30
1
Pro Hac Vice fee received for James J. Haley, Jr., Esq., Christopher J. Harnett, Esq., William J. McCabe, Esq., Pablo D. Hendler, Esq., Anthony A. Pastor, Esq., Bradford J. Badke, Esq., Jordan S. Adler, Esq. and Kaede Toh, Esq.: $1,200, receipt number NEW002713 (mmh)
2010-08-30
1
No Actions
Certification of Arnold B. Calmann, Esq. in Support of Application for Admission Pro Hac Vice on behalf of DYAX CORPORATION, FOREST LABORATORIES, INC., GENZYME CORPORATION, GLAXOSMITHKLINE LLC, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., PERKINELMER HEALTH SCIENCES, INC. Re 57 Order on Motion for Leave to Appear. (Attachments: # 1 Declaration of Bradford James Badke, Esq. In Support of Application for Admission Pro Hac Vice)(CALMANN, ARNOLD) (Entered: 08/31/2010)
2010-08-31
1
Certification of Arnold B. Calmann, Esq. in Support of Application for Admission Pro Hac Vice on behalf of DYAX CORPORATION, FOREST LABORATORIES, INC., GENZYME CORPORATION, GLAXOSMITHKLINE LLC, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., PERKINELMER HEALTH SCIENCES, INC. Re 57 Order on Motion for Leave to Appear. (Attachments: # 1 Declaration of Bradford James Badke, Esq. In Support of Application for Admission Pro Hac Vice)(CALMANN, ARNOLD) (Entered: 08/31/2010)
2010-08-31
2
Notice of Request by Pro Hac Vice James J. Haley, Jr., Esq., Christopher J. Harnett, Esq., William J. McCabe, Esq., Pablo D. Hendler, Esq., Anthony A. Pastor, Esq., Bradford J. Badke, Esq., Jordan S. Adler, Esq., and Kaede Toh, Esq. to receive Notices of Electronic Filings. (ALBIN, GERI) (Entered: 08/31/2010)
2010-08-31
1
Letter from Liza M. Walsh re 55 Letter. (Attachments: # 1 Text of Proposed Order)(WALSH, LIZA) (Entered: 08/31/2010)
2010-08-31
1
Letter from Liza M. Walsh re 55 Letter. (Attachments: # 1 Text of Proposed Order)(WALSH, LIZA) (Entered: 08/31/2010)
2010-08-31
2
Pro Hac Vice fee received for Robert J. Koch, Esq.: $150, receipt number NEW002740 (mmh)
2010-08-31
1
No Actions
APPLICATION/PETITION for Pro Hac Vice Admission of Bradford James Badke, Esq. for by DYAX CORPORATION, FOREST LABORATORIES, INC., GENZYME CORPORATION, GLAXOSMITHKLINE LLC, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., PERKINELMER HEALTH SCIENCES, INC.. (Attachments: # 1 Declaration of Bradford James Badke, Esq. In Support of Application for Admission Pro Hac Vice)(CALMANN, ARNOLD) (Entered: 09/01/2010)
2010-09-01
1
APPLICATION/PETITION for Pro Hac Vice Admission of Bradford James Badke, Esq. for by DYAX CORPORATION, FOREST LABORATORIES, INC., GENZYME CORPORATION, GLAXOSMITHKLINE LLC, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., PERKINELMER HEALTH SCIENCES, INC.. (Attachments: # 1 Declaration of Bradford James Badke, Esq. In Support of Application for Admission Pro Hac Vice)(CALMANN, ARNOLD) (Entered: 09/01/2010)
2010-09-01
2
Pro Hac Vice fee received for Matthew M. Wolf, Esq. and Jennifer A. Sklenar, Esq.: $300, receipt number TRE004615. (mmh)
2010-09-01
1
No Actions
CLERK'S QUALITY CONTROL MESSAGE - The Application for Pro Hac Admission 65 filed by A. Calmann, Esq. on 8/31/2010 was submitted incorrectly as a Certification. PLEASE RESUBMIT THE Application for Pro Hac Admission USING the event APPLICATION/PETITION found under OTHER FILINGS -> OTHER DOCUMENTS. This submission will remain on the docket unless otherwise ordered by the court. (gxh)
2010-09-01
1
No Actions
Certification on behalf of QIAGEN INCORPORATED. (Attachments: # 1 Certification of Theresa M. Gillis, # 2 Certificate of Service)(WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
1
Certification on behalf of QIAGEN INCORPORATED. (Attachments: # 1 Certification of Theresa M. Gillis, # 2 Certificate of Service)(WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
2
Certification on behalf of QIAGEN INCORPORATED. (Attachments: # 1 Certification of Theresa M. Gillis, # 2 Certificate of Service)(WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
2
Notice of Request by Pro Hac Vice Theresa M. Gillis to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3301617.) (WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
1
ORDER that the Clerk is directed to reissue summonses for Defts Novo Nordisk, Inc. and Bracco Diagnostics, Inc.. Signed by Judge Joel A. Pisano on 9/2/2010. (gxh) (Entered: 09/02/2010)
2010-09-02
1
Notice of Request by Pro Hac Vice Michael Siem to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3301727.) (WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
1
Notice of Request by Pro Hac Vice Brian D. Coggio to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3301746.) (WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
1
SUMMONS ISSUED as to BRACCO DIAGNOSTICS INC., NOVO NORDISK, INC. with answer to complaint due within 21 days. (eaj) (Entered: 09/02/2010)
2010-09-02
1
Certification of Liza M. Walsh on behalf of QIAGEN INCORPORATED. (Attachments: # 1 Certification of Theresa M. Gillis (Amended), # 2 Certificate of Service (Amended))(WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
1
Certification of Liza M. Walsh on behalf of QIAGEN INCORPORATED. (Attachments: # 1 Certification of Theresa M. Gillis (Amended), # 2 Certificate of Service (Amended))(WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
2
Certification of Liza M. Walsh on behalf of QIAGEN INCORPORATED. (Attachments: # 1 Certification of Theresa M. Gillis (Amended), # 2 Certificate of Service (Amended))(WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
2
Notice of Request by Pro Hac Vice W. Chad Shear to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3301797.) (WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
1
Notice of Request by Pro Hac Vice Aine Skow to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3301812.) (WALSH, LIZA) (Entered: 09/02/2010)
2010-09-02
1
Pro Hac Vice fee received for Mark A. Pals, Esq., Tiffany P. Cunningham, Esq. and Elizabeth A. Nemo, Esq.: $450, receipt number TRE004654 (mmh)
2010-09-02
1
No Actions
Pro Hac Vice fee received for David K. Barr, Esq. and Richard G. Greco, Esq.: $300, receipt number TRE004653 (mmh)
2010-09-02
1
No Actions
ORDER that Plaintiff shall file an Affidavit of Service that includes certain information as specified in this Order. Signed by Judge Joel A. Pisano on 9/2/2010. (mmh) (Entered: 09/03/2010)
2010-09-03
1
AFFIDAVIT of Service for Summons and Complaint served on Novo Nordisk, Inc. and Bracco Diagnostics, Inc., filed by GEORGE PIECZENIK. (gxh) (Entered: 09/07/2010)
2010-09-07
1
Notice of Request by Pro Hac Vice Tiffany P. Cunningham, Mark A. Pals and Elizabeth A. Nemo to receive Notices of Electronic Filings. (FLAHERTY, JOHN) (Entered: 09/07/2010)
2010-09-07
1
NOTICE of Voluntary Dismissal as to Deft DIVERSA CHEMICAL TECHNOLOGIES (NJ) INC. by GEORGE PIECZENIK. (gxh) (Entered: 09/07/2010)
2010-09-07
1
Notice of Request by Pro Hac Vice David K. Barr and Richard G. Grecco to receive Notices of Electronic Filings. (FLAHERTY, JOHN) (Entered: 09/07/2010)
2010-09-07
1
SUMMONS Returned Executed by GEORGE PIECZENIK. NOVO NORDISK, INC. served on 9/7/2010, answer due 9/28/2010. (gxh) (Entered: 09/07/2010)
2010-09-07
1
SUMMONS Returned Executed by GEORGE PIECZENIK. BRACCO DIAGNOSTICS INC. served on 9/7/2010, answer due 9/28/2010. (gxh) (Entered: 09/07/2010)
2010-09-07
1
Pro Hac Vice fee received for Bruce C. Haas, Esq., Lisa Barons Pensabene, Esq. and Nichaols M. Cannella, Esq.: $450, receipt number TRE004751 (mmh)
2010-09-07
1
No Actions
Pro Hac Vice fee received for Michael D. Kaminski, Esq.: $150, receipt number TRE004749 (mmh)
2010-09-07
1
No Actions
NOTICE AND ORDER of dismissal without prejudice as to Deft DIVERSA CHEMICAL TECHNOLOGIES (NJ) INC.. Signed by Judge Joel A. Pisano on 9/7/2010. (gxh) (Entered: 09/08/2010)
2010-09-08
1
Substitution of Attorney terminating Ethan J. Steward as to deft. DOW CHEMICAL COMPANY. Added attorney Elizabeth S. Hyon (HYON, ELIZABETH) Modified on 9/8/2010 (lk). (Entered: 09/08/2010)
2010-09-08
1
Notice of Request by Pro Hac Vice Nagendra Setty to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3307544.) (WALSH, LIZA) (Entered: 09/08/2010)
2010-09-08
1
Notice of Request by Pro Hac Vice Noah C. Graubart to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3307548.) (WALSH, LIZA) (Entered: 09/08/2010)
2010-09-08
1
Notice of Request by Pro Hac Vice Bruce C. Haas, Lisa Barons Pensabene & Nicholas M. Cannella to receive Notices of Electronic Filings. (FLAHERTY, JOHN) (Entered: 09/08/2010)
2010-09-08
1
NOTICE of Appearance by ELIZABETH SUSAN HYON on behalf of THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION (HYON, ELIZABETH) (Entered: 09/08/2010)
2010-09-08
1
Notice of Request by Pro Hac Vice Thomas F. Fleming to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3311031.) (O'REILLY, TRICIA) (Entered: 09/10/2010)
2010-09-10
1
Notice of Request by Pro Hac Vice Oliver C. Bennett to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3311048.) (O'REILLY, TRICIA) (Entered: 09/10/2010)
2010-09-10
1
Pro Hac Vice fee received for Matthew D. Murphey, Esq. and Andrea K. Douglas, Esq.: $300, receipt number TRE004883 (mmh)
2010-09-10
1
No Actions
NOTICE by INVITROGEN CORPORATION Notice of Request by Pro Hac Vice Andrea K. Douglas (Attachments: # 1 Certificate of Good Standing)(SHILOH, ELIOR) (Entered: 09/13/2010)
2010-09-13
1
NOTICE by INVITROGEN CORPORATION Notice of Request by Pro Hac Vice Andrea K. Douglas (Attachments: # 1 Certificate of Good Standing)(SHILOH, ELIOR) (Entered: 09/13/2010)
2010-09-13
2
NOTICE by INVITROGEN CORPORATION Notice of Request by Pro Hac Vice Matthew D. Murphey (Attachments: # 1 Certification Certificate of Good Standing)(SHILOH, ELIOR) (Entered: 09/13/2010)
2010-09-13
1
NOTICE by INVITROGEN CORPORATION Notice of Request by Pro Hac Vice Matthew D. Murphey (Attachments: # 1 Certification Certificate of Good Standing)(SHILOH, ELIOR) (Entered: 09/13/2010)
2010-09-13
2
Notice of Request by Pro Hac Vice Charles E. Lipsey, Susan Griffen, Courtney B. Casp & Victoria Lee to receive Notices of Electronic Filings. (FLAHERTY, JOHN) (Entered: 09/14/2010)
2010-09-14
1
Pro Hac Vice fee received for Charles E. Lipsey, Esq., Susan H. Griffen, Esq., Courtney B. Casp, Esq. and Victoria S. Lee, Esq.: $600, receipt number TRE004946 (mmh)
2010-09-14
1
No Actions
APPLICATION/PETITION for Admission Pro Hac Vice for by INVITROGEN CORPORATION. (Attachments: # 1 Declaration Matthew Murphey, # 2 Declaration Andrea K. Douglas)(SHILOH, ELIOR) (Entered: 09/15/2010)
2010-09-15
1
APPLICATION/PETITION for Admission Pro Hac Vice for by INVITROGEN CORPORATION. (Attachments: # 1 Declaration Matthew Murphey, # 2 Declaration Andrea K. Douglas)(SHILOH, ELIOR) (Entered: 09/15/2010)
2010-09-15
2
APPLICATION/PETITION for Admission Pro Hac Vice for by INVITROGEN CORPORATION. (Attachments: # 1 Declaration Matthew Murphey, # 2 Declaration Andrea K. Douglas)(SHILOH, ELIOR) (Entered: 09/15/2010)
2010-09-15
2
Pro Hac Vice fee received for Eric J. Marandett, Esq. and Ginger Hsu, Esq.: $300, receipt number NEW002934. (gxh)
2010-09-15
1
No Actions
Notice of Request by Pro Hac Vice Eric J. Marandett and Ginger Hsu to receive Notices of Electronic Filings. (LEIT, DAVID) (Entered: 09/16/2010)
2010-09-16
1
ORDER granting leave to appear pro hac vice as to Daniel J. Brown, Esq. and Heather D. Redmond, Esq. on behalf of Defts Syngenta. Signed by Magistrate Judge Tonianne J. Bongiovanni on 9/16/2010. (gxh) (Entered: 09/17/2010)
2010-09-17
1
Notice of Request by Pro Hac Vice Daniel J. Brown to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3324882.) (MCKENNA, KEVIN) (Entered: 09/17/2010)
2010-09-17
1
Notice of Request by Pro Hac Vice Heather D. Redmond to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3324889.) (MCKENNA, KEVIN) (Entered: 09/17/2010)
2010-09-17
1
Letter from Liza M. Walsh. (WALSH, LIZA) (Entered: 09/17/2010)
2010-09-17
1
Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney WILLIAM J. HELLER terminated. (HELLER, WILLIAM) (Entered: 09/17/2010)
2010-09-17
1
ORDER granting leave to appear pro hac vice as to Andrea K. Douglas, Esq. and Matthew Murphey, Esq. on behalf of Deft Invitrogen Corporation. Signed by Magistrate Judge Tonianne J. Bongiovanni on 9/20/2010. (gxh) (Entered: 09/20/2010)
2010-09-20
1
Certification of Liza M. Walsh on behalf of IDEXX REFERENCE LABORATORIES, INC.. (Attachments: # 1 Certification of Daniel A. Boehnen, # 2 Certification of Joshua R. Rich, # 3 Certificate of Service)(WALSH, LIZA) (Entered: 09/21/2010)
2010-09-21
1
Certification of Liza M. Walsh on behalf of IDEXX REFERENCE LABORATORIES, INC.. (Attachments: # 1 Certification of Daniel A. Boehnen, # 2 Certification of Joshua R. Rich, # 3 Certificate of Service)(WALSH, LIZA) (Entered: 09/21/2010)
2010-09-21
2
Certification of Liza M. Walsh on behalf of IDEXX REFERENCE LABORATORIES, INC.. (Attachments: # 1 Certification of Daniel A. Boehnen, # 2 Certification of Joshua R. Rich, # 3 Certificate of Service)(WALSH, LIZA) (Entered: 09/21/2010)
2010-09-21
2
Certification of Liza M. Walsh on behalf of IDEXX REFERENCE LABORATORIES, INC.. (Attachments: # 1 Certification of Daniel A. Boehnen, # 2 Certification of Joshua R. Rich, # 3 Certificate of Service)(WALSH, LIZA) (Entered: 09/21/2010)
2010-09-21
2
Notice of Request by Pro Hac Vice Daniel A. Boehnen to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3330803.) (WALSH, LIZA) (Entered: 09/21/2010)
2010-09-21
1
Notice of Request by Pro Hac Vice Joshua R. Rich to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-3330820.) (WALSH, LIZA) (Entered: 09/21/2010)
2010-09-21
1
Notice of Request by Pro Hac Vice Michael D. Kaminski to receive Notices of Electronic Filings. (SEKEL, ANNE) (Entered: 09/22/2010)
2010-09-22
1
Per Counsel regarding QC message dated 9/22/10 please see Court's order document 59 regarding pro hac vice addmissions. Clerk will enter notice to receive notification as to pro hac vice counsel for attorneys Boehmen & Rich. (lk)
2010-09-22
1
No Actions
CLERK'S QUALITY CONTROL MESSAGE - Regarding documents 105 & 106 request to receive Notices of electronic filing filed by L. Walsh, Esq. on 9/21/10. There is no order admitting either attorney, therefore they can not be added at this time. Once an order is filed please resubmit the request to be notified. (lk)
2010-09-22
1
No Actions
Notice of Request by Pro Hac Vice Matthew D. Murphey to receive Notices of Electronic Filings. (SHILOH, ELIOR) (Entered: 09/23/2010)
2010-09-23
1
Notice of Request by Pro Hac Vice Andrea K. Douglas to receive Notices of Electronic Filings. (SHILOH, ELIOR) (Entered: 09/23/2010)
2010-09-23
1
Notice of Request by Pro Hac Vice Jennifer A. Sklenar, Esq. to receive Notices of Electronic Filings. (Attachments: # 1 Certificate of Service)(GREWAL, GURBIR) (Entered: 09/27/2010)
2010-09-27
1
Notice of Request by Pro Hac Vice Jennifer A. Sklenar, Esq. to receive Notices of Electronic Filings. (Attachments: # 1 Certificate of Service)(GREWAL, GURBIR) (Entered: 09/27/2010)
2010-09-27
2
Notice of Request by Pro Hac Vice Matthew M. Wolf. Esq. to receive Notices of Electronic Filings. (Attachments: # 1 Certificate of Service)(GREWAL, GURBIR) (Entered: 09/27/2010)
2010-09-27
1
Notice of Request by Pro Hac Vice Matthew M. Wolf. Esq. to receive Notices of Electronic Filings. (Attachments: # 1 Certificate of Service)(GREWAL, GURBIR) (Entered: 09/27/2010)
2010-09-27
2
Notice of Request by Pro Hac Vice Donald R. Ware and Jeremy A. Younkin to receive Notices of Electronic Filings. (BUCKINGHAM, STEPHEN) (Entered: 09/29/2010)
2010-09-29
1
Pro Hac Vice fee received for Donald R. Ware, Esq. and Jeremy A. Younkin, Esq.: $300, receipt number TRE005276 (mmh)
2010-09-29
1
No Actions
Letter from Liza M. Walsh. (WALSH, LIZA) (Entered: 10/20/2010)
2010-10-20
1
NOTICE of Appearance by ALEXANDER JOHN ANGLIM on behalf of BRACCO DIAGNOSTICS INC. (ANGLIM, ALEXANDER) (Entered: 10/21/2010)
2010-10-21
1
LETTER ORDER grant request regarding brief. Signed by Judge Joel A. Pisano on 10/21/10. (lk) (Entered: 10/21/2010)
2010-10-21
1
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
1
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
MOTION to Dismiss the Amended Complaint by ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., ALLERGAN USA, INC., AMGEN INC., AMGEN USA, INC., ANTYRA, INC., ASTELLAS PHARMA US, INC., ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, AVENTIS INC., AVENTIS PHARMACEUTICALS INC., BAXTER DIAGNOSTICS INC., BAYER CORPORATION, BAYER CROPSCIENCE (New Jersey) INC., BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER MATERIALSCIENCE LLC, BAYER PHARMA CHEMICALS INC., BAYER PHARMACEUTICALS CORPORATION, BIOGEN IDEC INC., BIOGEN IDEC U.S. CORPORATION, BOEHRINGER INGELHEIM VETMEDICA, INC., BOEHRINGER INGELHEIMROXANE, INC., BRACCO DIAGNOSTICS INC., CANON, U.S.A. INC., CENTOCOR ORTHO BIOTECH PRODUCTS, L.P., CENTOCOR ORTHO BIOTECH SERVICES, CENTOCOR ORTHO BIOTECH, INC., CORNING INCORPORATED, DAIICHI SANKYO, INC., DAINIPPON SUMITOMO PHARMA AMERICA HOLDINGS, INC., DAINIPPON SUMITOMO PHARMA AMERICA, INC., DYAX CORPORATION, E.I. DUPONT DENEMOURS AND COMPANY, FOREST LABORATORIES, INC., GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION, GENZYME CORPORATION, GILEAD SCIENCES, INC., GLAXOSMITHKLINE LLC, HOWARD HUGHES MEDICAL INSTITUTE, IDEXX REFERENCE LABORATORIES, INC., INTERNATIONAL BUSINESS MACHINES CORP., INVITROGEN CORPORATION, JOHNSON & JOHNSON, KYOWA HAKKO KIRIN AMERICA, INC., KYOWA HAKKO KIRIN PHARMA, INC., MEDAREX, INC., MEDIMMUNE LLC, MILLENIUM PHARMACEUTICALS, INC., MITSUBISHI TANABE PHARMA AMERICA, INC., MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC., MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC., MONSANTO AG PRODUCTS LLC, MONSANTO COMPANY, NOVARTIS CORPORATION, NOVARTIS PHARMACEUTICAL CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS, INC., NOVO NORDISK, INC., ONYX PHARMACEUTICALS, INC., ORTHO-MCNEIL JANSSEN SCIENTIFIC AFFAIRS, LLC, ORTHO-MCNEIL PHARMACEUTICAL, INC., ORTHO-MCNEIL, INC., OSI PHARMACEUTICALS, INC., PERKINELMER HEALTH SCIENCES, INC., PHARMACIA & UPJOHN COMPANY LLC, PHARMACIA CORPORATION, QIAGEN INCORPORATED, SANOFI-AVENTIS U.S. INC., SANOFI-AVENTIS U.S. LLC, SCHERING BERLIN INC., SCHERING CORPORATION, SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC., SIEMENS CORPORATION, SIEMENS DIAGNOSTICS FINANCE CO. LLC, SIEMENS HEALTHCARE DIAGNOSTICS INC., SIEMENS MEDICAL SOLUTIONS USA, INC., SOLVAY CHEMICALS, INC., SOLVAY PHARMACEUTICALS, INC., SYNGENTA CROP PROTECTION, INC., SYNGENTA SEEDS, INC., TAIHO PHARMA U.S.A., INC., THE DOW AGROSCIENCES LLC, THE DOW CHEMICAL COMPANY (DELAWARE), THE DOW CORNING CORPORATION, WYETH HOLDINGS CORPORATION, WYETH PHARMACEUTICALS INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC. (Attachments: # 1 Consolidated Brief in Support of Defendants' Motion to Dismiss, # 2 Declaration of Jordan S. Adler, # 3 Declaration of Bruce C. Haas for Astellas Pharma US Inc., # 4 Declaration of Victoria Lee for AstraZeneca LP and AstraZeneca Pharmaceuticals LP, # 5 Declaration of Constantine Koutsoubas for Johnson & Johnson et al., # 6 Declaration of Victoria Lee for Mitsubishi Tanabe Pharma America, Inc. et al., # 7 Declaration of Rukhsanah L. Lighari for Qiagen Incorporated, # 8 Declaration of Noah C. Graubart for Shionogi Pharma Sales, Inc. et al., # 9 Text of Proposed Order, # 10 Certificate of Service)(WALSH, LIZA) (Entered: 10/22/2010)
2010-10-22
2
Set Deadlines as to 116 MOTION to Dismiss the Amended Complaint. Motion set for 11/15/2010 before Judge Joel A. Pisano. The motion will be decided on the papers. No appearances required unless notified by the court. (ss, )
2010-10-25
1
No Actions
BRIEF in Opposition re 116 MOTION to Dismiss the Amended Complaint filed by GEORGE PIECZENIK. (gxh) (Entered: 11/01/2010)
2010-11-01
1
MOTION in Limine to Expunge Plaintiff's Copyright Lecture Proferred by Defendants' Counsel and to Charge them with Digital Copyright Infringement by GEORGE PIECZENIK. (gxh) (Entered: 11/01/2010)
2010-11-01
1
MOTION for Reconsideration re 57 Order on Motion for Leave to Appear by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A)(gxh) (Entered: 11/01/2010)
2010-11-01
1
MOTION for Reconsideration re 57 Order on Motion for Leave to Appear by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A)(gxh) (Entered: 11/01/2010)
2010-11-01
2
MOTION for Mediation by GEORGE PIECZENIK. (gxh) (Entered: 11/01/2010)
2010-11-01
1
Set Deadlines as to 118 MOTION in Limine to Expunge Plaintiff's Copyright Lecture Proferred by Defendants' Counsel and to Charge them with Digital Copyright Infringement. Motion set for 12/6/2010 before Judge Joel A. Pisano. The motion will be decided on the papers. No appearances required unless notified by the court. (gxh)
2010-11-01
1
No Actions
Set Deadlines as to 119 MOTION for Reconsideration re 57 Order on Motion for Leave to Appear, 120 MOTION for Mediation. Motion set for 12/6/2010 before Magistrate Judge Tonianne J. Bongiovanni. The motion will be decided on the papers. No appearances required unless notified by the court. (gxh)
2010-11-01
1
No Actions
Letter from Liza M. Walsh re 117 Brief in Opposition to Motion, 120 MOTION Mediation. (WALSH, LIZA) (Entered: 11/08/2010)
2010-11-08
1
Letter from Liza M. Walsh re 118 MOTION in Limine. (WALSH, LIZA) (Entered: 11/08/2010)
2010-11-08
1
Letter from Robert M. Goodman re 119 MOTION for Reconsideration re 57 Order on Motion for Leave to Appear. (GOODMAN, ROBERT) (Entered: 11/08/2010)
2010-11-08
1
NOTICE by GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION of Withdrawal of Gurbir S. Grewal, Esq. as Counsel of Record and Substitution of John Fedun, Esq. (Attachments: # 1 Certificate of Service)(GREWAL, GURBIR) (Entered: 11/22/2010)
2010-11-22
1
NOTICE by GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION of Withdrawal of Gurbir S. Grewal, Esq. as Counsel of Record and Substitution of John Fedun, Esq. (Attachments: # 1 Certificate of Service)(GREWAL, GURBIR) (Entered: 11/22/2010)
2010-11-22
2
SUBSTITUTION OF ATTORNEY. (Attachments: # 1 Certificate of Service)(GREWAL, GURBIR) Modified on 11/24/2010 (eaj). Edited to add docket text. (Entered: 11/23/2010)
2010-11-23
1
SUBSTITUTION OF ATTORNEY. (Attachments: # 1 Certificate of Service)(GREWAL, GURBIR) Modified on 11/24/2010 (eaj). Edited to add docket text. (Entered: 11/23/2010)
2010-11-23
2
CLERK'S QUALITY CONTROL MESSAGE - The 124 SUBSTITUTION OF ATTORNEY filed by G. GREWAL on 11/22/2010 was submitted incorrectly as a NOTICE. PLEASE RESUBMIT THE document USING SUBSTITUTION OF ATTORNEY located in the OTHER DOCUMENTS category. This submission will remain on the docket unless otherwise ordered by the court. (ss, )
2010-11-23
1
No Actions
ORDER denying 118 Motion in Limine; and denying 120 Motion for Mediation. Signed by Judge Joel A. Pisano on 12/2/10. (lk) (Entered: 12/02/2010)
2010-12-02
1
NOTICE OF APPEAL as to 126 Order denying 118 Motion in Limine; and denying 120 Motion for Mediation by GEORGE PIECZENIK. Filing fee $ 455, receipt number TRE007044. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (Attachments: # 1 Exhibit A)(mmh) Modified receipt number on 12/6/2010 (mmh). (Entered: 12/03/2010)
2010-12-03
1
NOTICE OF APPEAL as to 126 Order denying 118 Motion in Limine; and denying 120 Motion for Mediation by GEORGE PIECZENIK. Filing fee $ 455, receipt number TRE007044. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (Attachments: # 1 Exhibit A)(mmh) Modified receipt number on 12/6/2010 (mmh). (Entered: 12/03/2010)
2010-12-03
2
NOTICE OF APPEAL to Federal Circuit as to 126 ORDER denying 118 Motion in Limine; and denying 120 Motion for Mediation by GEORGE PIECZENIK. Filing fee $ 455, receipt number TRE007044. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (Attachments: # 1 Exhibit A)(mmh) (Entered: 12/09/2010)
2010-12-03
1
NOTICE OF APPEAL to Federal Circuit as to 126 ORDER denying 118 Motion in Limine; and denying 120 Motion for Mediation by GEORGE PIECZENIK. Filing fee $ 455, receipt number TRE007044. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (Attachments: # 1 Exhibit A)(mmh) (Entered: 12/09/2010)
2010-12-03
2
128 Notice of Appeal forwarded to the USCA for the Federal Circuit, Washington D.C. (mmh) (mmh). (Entered: 12/09/2010)
2010-12-09
1
CLERK'S QUALITY CONTROL MESSAGE - Please note the Notice of Appeal attached to docket entry 127 filed by the Clerk's office on 12/3/2010 was docketed using the incorrect event. Please disregard. (mmh)
2010-12-09
1
No Actions
LETTER ORDER denying 119 Pltf's Motion for Reconsideration. Signed by Magistrate Judge Tonianne J. Bongiovanni on 12/9/2010. (gxh) (Entered: 12/10/2010)
2010-12-10
1
NOTICE OF APPEAL to Federal Circuit as to 130 LETTER ORDER denying 119 Pltf's Motion for Reconsideration by GEORGE PIECZENIK. Filing fee $ 455, receipt number TRE007352. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (Attachments: # 1 Exhibit A)(mmh) (Entered: 12/14/2010)
2010-12-14
1
NOTICE OF APPEAL to Federal Circuit as to 130 LETTER ORDER denying 119 Pltf's Motion for Reconsideration by GEORGE PIECZENIK. Filing fee $ 455, receipt number TRE007352. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (Attachments: # 1 Exhibit A)(mmh) (Entered: 12/14/2010)
2010-12-14
2
131 Notice of Appeal forwarded to the USCA for the Federal Circuit, Washington D.C. (mmh)
2010-12-14
1
No Actions
USCA Notice of Docketing re 128 Notice of Appeal. USCA Case Number 2011-1121. (mmh) (Entered: 12/16/2010)
2010-12-16
1
NOTICE of Appearance by CHAD JOHNSON PETERMAN on behalf of ABBOTT LABORATORIES, ABBOTT LABORATORIES, INC., SOLVAY PHARMACEUTICALS, INC. (PETERMAN, CHAD) (Entered: 12/29/2010)
2010-12-29
1
Corporate Disclosure Statement by SHIONOGI PHARMA SALES, INC., SHIONOGI PHARMA, INC., SHIONOGI USA HOLDINGS, INC., SHIONOGI USA, INC. identifying Shionogi Inc. and Shionogi & Co., Ltd. as Corporate Parent.. (WALSH, LIZA) (Entered: 01/03/2011)
2011-01-03
1
NOTICE AND ORDER of dismissal with prejudice as to PHARMACIA CORPORATION, PHARMACIA & UPJOHN COMPANY LLC, WYETH PHARMACEUTICALS and WYETH HOLDINGS CORPORATION. Signed by Judge Joel A. Pisano on 1/11/2011. (gxh) (Entered: 01/11/2011)
2011-01-11
1
NOTICE AND ORDER Dismissing all claims against SCHERING-PLOUGH BIOPHARMA, SCHERING-PLOUGH INTERNATIONAL, INC., SCHERING-PLOUGH PRODUCTS, INC., and SCHERING CORPORATION, with prejudice.. Signed by Judge Joel A. Pisano on 1/25/2011. (eaj) Modified on 1/28/2011 (eaj). (Entered: 01/25/2011)
2011-01-25
1
NOTICE of Voluntary Dismissal of Deft IDEXX Reference Laboratories, Inc. by GEORGE PIECZENIK. (gxh) (Entered: 02/02/2011)
2011-02-01
1
NOTICE of Substitution of Counsel by INVITROGEN CORPORATION (Attachments: # 1 Text of Proposed Order for Substitution of Attorney)(eaj) (Entered: 02/03/2011)
2011-02-01
1
NOTICE of Substitution of Counsel by INVITROGEN CORPORATION (Attachments: # 1 Text of Proposed Order for Substitution of Attorney)(eaj) (Entered: 02/03/2011)
2011-02-01
2
NOTICE AND ORDER that all claims against IDEXX are scheduled for an in-person Status Hearing on 2/10/2011 at 11:00 AM in Trenton - Courtroom 1 before Judge Joel A. Pisano. Signed by Judge Joel A. Pisano on 2/3/2011. (gxh) (Entered: 02/07/2011)
2011-02-03
1
In-Person Status Conference set for 2/10/2011 02:30 PM (TIME CHANGE ONLY) in Trenton - Courtroom 1 before Judge Joel A. Pisano. (DS, )
2011-02-08
1
No Actions
ORDER that Plaintiff's oral motion is denied without prejudice to Plaintiff filing a formal motion for recusal; further ordered that Plaintiff may file a motion for recusal no later than 14 days after entry of this Order. Signed by Judge Joel A. Pisano on 2/10/2011. (eaj) (Entered: 02/10/2011)
2011-02-10
1
Minute Entry for proceedings held before Judge Joel A. Pisano: In-Person Status Conference held on 2/10/2011. (Court Reporter J. Caruso.) (DS) (Entered: 02/10/2011)
2011-02-10
1
NOTICE AND ORDER DISMISSING ALL CLAIMS against Defendant IDEXX REFERENCE LABORATORIES, INC., with prejudice. Signed by Judge Joel A. Pisano on 2/14/2011. (eaj) (Entered: 02/14/2011)
2011-02-14
1
NOTICE of Appearance by LAURA E. KRAWCZYK on behalf of INVITROGEN CORPORATION (KRAWCZYK, LAURA) (Entered: 02/14/2011)
2011-02-14
1
Transcript of IN-PERSON STATUS CONFERENCE held on 2/10/2011, before Judge JOEL A. PISANO. Court Reporter/Transcriber JOANNE M. CARUSO, Telephone number (908) 334-2472. NOTICE REGARDING REDACTION OF TRANSCRIPTS: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript. Redaction Request due 3/8/2011. Redacted Transcript Deadline set for 3/18/2011. Release of Transcript Restriction set for 5/16/2011. (mmh) (Entered: 02/15/2011)
2011-02-15
1
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
1
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
MOTION for Recusal by GEORGE PIECZENIK. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(gxh) (Entered: 02/23/2011)
2011-02-23
2
Set Deadlines as to 145 MOTION for Recusal. Motion set for 3/21/2011 before Judge Joel A. Pisano. The motion will be decided on the papers. No appearances required unless notified by the court. (gxh)
2011-02-23
1
No Actions
NOTICE of Appearance by JENNIFER L. LARSON on behalf of GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION (LARSON, JENNIFER) (Entered: 03/16/2011)
2011-03-16
1
NOTICE by GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION Notice of Change of Firm Affiliation and Address of Matthew M. Wolf and Jennifer A. Sklenar (LARSON, JENNIFER) (Entered: 03/17/2011)
2011-03-17
1
NOTICE by QIAGEN INCORPORATED of Change of Firm Affiliation and Address of Pro Hac Vice Counsel (WALSH, LIZA) (Entered: 03/23/2011)
2011-03-23
1
Letter from Liza M. Walsh. (Attachments: # 1 Dismissal with Prejudice as to Certain Defendants and proposed Order)(WALSH, LIZA) (Entered: 03/23/2011)
2011-03-23
1
Letter from Liza M. Walsh. (Attachments: # 1 Dismissal with Prejudice as to Certain Defendants and proposed Order)(WALSH, LIZA) (Entered: 03/23/2011)
2011-03-23
2
OPINION. Signed by Judge Joel A. Pisano on 3/23/2011. (gxh) (Entered: 03/23/2011)
2011-03-23
1
ORDER granting 116 Defts' Motion to Dismiss; that Pltf's Amended Complaint is DISMISSED with prejudice; denying 145 Pltf's Motion for Recusal. Signed by Judge Joel A. Pisano on 3/23/2011. (gxh) (Entered: 03/23/2011)
2011-03-23
1
***Civil Case Terminated. (gxh)
2011-03-23
1
No Actions
NOTICE OF APPEAL as to 150 Opinion, 151 Order on Motion to Dismiss, Order on Motion for Recusal by GEORGE PIECZENIK. Filing fee $ 455, receipt number TRE09888. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (mmh) (Entered: 03/24/2011)
2011-03-24
1
NOTICE OF APPEAL to Federal Circuit as to 150 Opinion, 151 Order on Motion to Dismiss, Order on Motion for Recusal by GEORGE PIECZENIK. Filing fee $455, receipt number TRE09888. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (mmh) (Entered: 03/28/2011)
2011-03-24
1
ORDER dismissing with prejudice all claims against certain Defts. Signed by Judge Joel A. Pisano on 3/24/2011. (gxh) (Entered: 03/25/2011)
2011-03-25
1
CLERK'S QUALITY CONTROL MESSAGE - Please note the Notice of Appeal attached to docket entry 152 filed by the Clerk's office on 3/24/2011 was docketed using the incorrect event and will be refiled using the correct event. Please disregard. (mmh)
2011-03-28
1
No Actions
154 Notice of Appeal forwarded to the USCA for the Federal Circuit, Washington D.C. (mmh)
2011-03-28
1
No Actions
MOTION to Withdraw as Counsel by GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION. (Attachments: # 1 Certificate of Service)(FEDUN, JOHN) (Entered: 04/15/2011)
2011-04-15
1
MOTION to Withdraw as Counsel by GE HEALTHCARE BIO-SCIENCES CORP., GE HEALTHCARE BIOSCIENCES BIOPROCESS CORP, GE HEALTHCARE INC., GE HEALTHCARE STRATEGIC SOURCING CORPORATION. (Attachments: # 1 Certificate of Service)(FEDUN, JOHN) (Entered: 04/15/2011)
2011-04-15
2
Set Deadlines as to 155 MOTION to Withdraw as Counsel. Motion set for 5/16/2011 before Judge Joel A. Pisano. The motion will be decided on the papers. No appearances required unless notified by the court. (jjc)
2011-04-18
1
No Actions
ORDER of USCA as to 154 Notice of Appeal, 131 Notice of Appeal filed by GEORGE PIECZENIK. The appeals are dismissed as premature. (mmh) (Entered: 05/05/2011)
2011-05-05
1
154 Notice of Appeal resent to the USCA for the Federal Circuit, Washington D.C. (mmh) (mmh). (Entered: 05/11/2011)
2011-05-11
1
USCA Case Number 2011-1385 for 154 Notice of Appeal (Federal Circuit), Notice of Appeal (Federal Circuit) filed by GEORGE PIECZENIK. (Document Restricted - Court Only) (mmh) (Entered: 05/19/2011)
2011-05-19
1
Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney CARRIE ANN LONGSTAFF terminated. (LONGSTAFF, CARRIE) (Entered: 05/31/2011)
2011-05-31
1
ORDER of USCA as to 154 Notice of Appeal, 128 Notice of Appeal filed by GEORGE PIECZENIK. The appeals are dismissed as premature. (mmh) (Entered: 06/13/2011)
2011-06-13
1
Pursuant to Local Rule 79.4, notice is hereby given of the Appellate ruling filed on 6/13/2011. In the event that the mandate or judgment provides for costs or directs a disposition other than an affirmance, the prevailing party shall prepare and submit an order implementing the mandate or judgment. (mmh)
2011-06-13
1
No Actions
Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney LAURA E. KRAWCZYK terminated. (KRAWCZYK, LAURA) (Entered: 06/29/2011)
2011-06-29
1
USCA OPINION and JUDGMENT as to 154 Notice of Appeal filed by GEORGE PIECZENIK. (mmh) (Entered: 03/26/2012)
2012-03-26
1
MANDATE of USCA as to 154 Notice of Appeal (USCA), filed by GEORGE PIECZENIK (Attachments: # 1 Certified Copy of Opinion)(mmh) (Entered: 05/03/2012)
2012-05-03
1
MANDATE of USCA as to 154 Notice of Appeal (USCA), filed by GEORGE PIECZENIK (Attachments: # 1 Certified Copy of Opinion)(mmh) (Entered: 05/03/2012)
2012-05-03
2
Pursuant to Local Rule 79.4, notice is hereby given of the Appellate ruling filed on 5/3/2012. In the event that the mandate or judgment provides for costs or directs a disposition other than an affirmance, the prevailing party shall prepare and submit an order implementing the mandate or judgment. (mmh)
2012-05-03
1
No Actions